Active Infection & Immunity Engineering

EPSRC and BBSRC Centre for Doctoral Training in Engineering Solutions for Antimicrobial Resistance

In plain English

AI plain-English summary

Antimicrobial resistance could cause an estimated 10 million deaths per year and cost the global economy US$100 trillion by 2050, yet the pipeline for new antibiotics has stalled. This Centre for Doctoral Training aims to address that gap by training physical scientists and engineers to develop practical solutions to antimicrobial resistance. Rather than focusing solely on drug discovery, the programme targets three areas where engineering and physical sciences can make a difference: preventing infections from spreading, improving surveillance and diagnostics, and developing new antimicrobials and vaccines. If successful, the centre will produce a cohort of researchers who can move beyond the lab. They will be equipped to navigate commercialisation, regulation, public health implementation, and public communication. The training programme is designed with input from public health bodies, multinational companies, SMEs, and charities, so the research has a clear route to real-world use. The impact would be felt in hospitals, water treatment systems, food supply chains, and other infrastructure where infection control matters. By building a skilled workforce that can turn engineering advances into deployable tools, the centre aims to slow the rise of drug-resistant infections before they become routine.

View original technical description
Infectious diseases come at a huge societal and economical cost. This has recently been shown by the COVID-19 pandemic. Looking forward, arguably the largest threat is antimicrobial resistance (AMR). As pathogens develop resistance against currently available antimicrobials (e.g., antibiotics) and as the development of new antimicrobials has stalled, we are risking an estimated 10M deaths per year globally and a US$100 trillion costs to the world economy by 2050. We here propose a Centre for Doctoral Training on Engineering Solutions for Antimicrobial Resistance, with the overall aim of training physical scientists and engineers with the specialist research skills as well as broad contextual skills to create rapid impact targeting the AMR challenge. This includes different disciplines and wider aspects such as commercialisation/translation, public-health context, regulation and standardisation, implementation and adoption, public awareness and perception, and communication. Identifying key research areas that depend on cutting-edge research advances in engineering and physical sciences, our Centre for Doctoral Training focuses on preventing the spread of infection, on surveillance and diagnostics, and on antimicrobial and vaccine development. By designing and delivering our training programme with public health institutions, multinational businesses, SMEs and charities, we maximise the impact of such research on addressing the public health threat of AMR and on exploiting business opportunities that are also associated with solutions to it.

View the original record at the funder ↗

Researchers

Bart Hoogenboom (Co-Investigator)Giorgio Volpe (Co-Investigator)Ingemar Cox (Co-Investigator)Joanne Santini (Co-Investigator)Manish K. Tiwari (Co-Investigator)Michael Thomas (Co-Investigator)Philip Pearce (Co-Investigator)Rachel McKendry (Co-Investigator)Richard Beckett (Co-Investigator)

Related Research

Grants with similar aims, by meaning.

STOP SPREAD BAD BUGS: novel antimicrobial approaches to combat multidrug resistance in bacteria
TARGeTED: Tackling Antimicrobial Resistance through Goal-orientated Thinking in the EPS Disciplines
Bridging the Gaps: Systems-level approaches to antimicrobial resistance
EPSRC Digital Health Hub for Antimicrobial Resistance
Engineering, Physical, Natural Sciences and Medicine Bridging Research in Antimicrobial resistance: Collaboration and Exchange (EMBRACE)

Original classification

Training Grant

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.